COVID-19 vaccine registry launched by Mayo to ID those interested in clinical trials

ROCHESTER, Minn. — Mayo Clinic has launched a COVID-19 Vaccine Registry for those interested in participating in upcoming COVID-19 vaccine clinical trials.

Right now, there are more than 150 vaccine candidates in preclinical evaluation and more than 40 in clinical trials worldwide, though those numbers fluctuate daily.

“In the coming months, Mayo Clinic will be holding trials at our campus in Rochester, Minnesota,” David Phelan, M.D., principal investigator of the COVID-19 Vaccine Registry, said in a statement. “We are starting this registry now so that when the time comes, we are positioned to quickly reach out to individuals who may be interested in participating. Our goal is to ensure scientific advances benefit our patients as quickly as possible.” Dr. Phelan is a hospitalist at Mayo Clinic.

To enroll, fill out the vaccine registery form by clicking here, or call 507-293-3383.

People who add their name to the registry may be contacted in the future to determine if they are eligible to participate in a COVID-19 vaccine trial at Mayo Clinic.

Mayo Clinic started planning for its registry by consulting with local communities for their guidance on how to engage underrepresented minorities and high-risk groups.

“We want to make sure that everyone in the community, including those who are most impacted by the pandemic, are aware of this registry and have the opportunity to decide if they want to be a part of it,” says Irene Sia, M.D., a Mayo Clinic health disparities researcher. “We need diverse participation if we want to find a vaccine that works for everyone.”